August 27, 2019 / 5:10 AM / 25 days ago

BRIEF-Santhera: ReveraGen Posts Positive Study Results For Vamorolone

Aug 27 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* SANTHERA ANNOUNCES PUBLICATION BY REVERAGEN OF POSITIVE PHASE IIA-EXTENSION STUDY RESULTS WITH VAMOROLONE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below